Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shou

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Toxicology|February 7, 2001
Detection of beryllium sensitivity using a flow cytometric lymphocyte proliferation test: the Immuno-Be-LPTG M Farris, L S Newman, E L Frome, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myelomaY Shou, M L Martelli, A Gabrea, et al.
Plos One|August 16, 2014
Phenotypic modulation of corpus cavernosum smooth muscle cells in a rat model of cavernous neurectomyFan Yang, Jian F Zhao, Qi Y Shou, et al.
Leukemia|July 6, 2007
UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemiaJ B Singer, Y Shou, F Giles, et al.
Blood Cancer Journal|October 18, 2014
Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphomaS E Assouline, J Chang, B D Cheson, et al.
Leukemia|November 15, 2011
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up resultsP D le Coutre, F J Giles, A Hochhaus, et al.
Leukemia|June 4, 2010
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapyF J Giles, E Abruzzese, G Rosti, et al.
BMC Genetics|December 2, 2010
High resolution mapping and positional cloning of ENU-induced mutations in the Rw region of mouse chromosome 5Yung-Hao Ching, Robert J Munroe, Jennifer L Moran, et al.
BMJ (Clinical Research Ed.)|May 31, 2020
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case seriesMichael G Argenziano, Samuel L Bruce, Cody L Slater, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case seriesMichael G Argenziano, Samuel L Bruce, Cody L Slater, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Toxicology|February 7, 2001
Detection of beryllium sensitivity using a flow cytometric lymphocyte proliferation test: the Immuno-Be-LPTG M Farris, L S Newman, E L Frome, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myelomaY Shou, M L Martelli, A Gabrea, et al.
Plos One|August 16, 2014
Phenotypic modulation of corpus cavernosum smooth muscle cells in a rat model of cavernous neurectomyFan Yang, Jian F Zhao, Qi Y Shou, et al.
Leukemia|July 6, 2007
UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemiaJ B Singer, Y Shou, F Giles, et al.
Blood Cancer Journal|October 18, 2014
Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphomaS E Assouline, J Chang, B D Cheson, et al.
Leukemia|November 15, 2011
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up resultsP D le Coutre, F J Giles, A Hochhaus, et al.
Leukemia|June 4, 2010
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapyF J Giles, E Abruzzese, G Rosti, et al.
BMC Genetics|December 2, 2010
High resolution mapping and positional cloning of ENU-induced mutations in the Rw region of mouse chromosome 5Yung-Hao Ching, Robert J Munroe, Jennifer L Moran, et al.
BMJ (Clinical Research Ed.)|May 31, 2020
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case seriesMichael G Argenziano, Samuel L Bruce, Cody L Slater, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case seriesMichael G Argenziano, Samuel L Bruce, Cody L Slater, et al.
Pageof 10